Related references
Note: Only part of the references are listed.Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Ana Luiza Mylla Boso et al.
CLINICAL OPHTHALMOLOGY (2020)
The use of preservatives in dry eye drops
Karen Walsh et al.
CLINICAL OPHTHALMOLOGY (2019)
Preservatives in glaucomamedication
David W. Steven et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2018)
Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients
Wissam Georges El Hajj Moussa et al.
JOURNAL OF OPHTHALMOLOGY (2018)
TFOS DEWS II iatrogenic report
Jose Alvaro P. Gomes et al.
OCULAR SURFACE (2017)
TFOS DEWS II pathophysiology report
Anthony J. Bron et al.
OCULAR SURFACE (2017)
TFOS DEWS II Sex, Gender, and Hormones Report
David A. Sullivan et al.
OCULAR SURFACE (2017)
In Vivo Confocal Imaging of the Conjunctiva as a Predictive Tool for the Glaucoma Filtration Surgery Outcome
Rodolfo Mastropasqua et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerability
Gemma Caterina Maria Rossi et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study
Joao F. Lopes et al.
BMC OPHTHALMOLOGY (2015)
Dry eye specific quality of life in veterans using glaucoma drops
Andrew Camp et al.
CONTACT LENS & ANTERIOR EYE (2015)
Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease
Ivan Goldberg et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2015)
Comparison of the ocular surface changes following the use of two different prostaglandin F2α analogues containing benzalkonium chloride or polyquad in rabbit eyes
Hyun Joo Lee et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2015)
Ocular Surface Disease Exacerbated Glaucoma: Optimizing the Ocular Surface Improves Intraocular Pressure Control
Ruchika Batra et al.
JOURNAL OF GLAUCOMA (2014)
Confocal Microscopy of Epithelial and Langerhans Cells of the Cornea in Patients Using Travoprost Drops Containing Two Different Preservatives
Laszlo Marsovszky et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
Ocular Surface Disease and Quality of Life in Patients With Glaucoma
Simon E. Skalicky et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Definition of glaucoma: clinical and experimental concepts
Robert J. Casson et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
Cytotoxicity and effects on metabolism of contact lens care solutions on human corneal epithelium cells
Camus K. M. Choy et al.
CLINICAL AND EXPERIMENTAL OPTOMETRY (2012)
Long-term Effect of BAK-free Travoprost on Ocular Surface and Intraocular Pressure in Glaucoma Patients After Transition From Latanoprost
Makoto Aihara et al.
JOURNAL OF GLAUCOMA (2012)
Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma
Ingrida Januleviciene et al.
CLINICAL OPHTHALMOLOGY (2012)
Polyquad-Preserved Travoprost/Timolol, Benzalkonium Chloride (BAK)-Preserved Travoprost/Timolol, and Latanoprost/Timolol in Fixed Combinations: a Rabbit Ocular Surface Study
Hong Liang et al.
ADVANCES IN THERAPY (2011)
Comparative In Vitro Toxicology Study of Travoprost Polyquad-preserved, Travoprost BAK-preserved, and Latanoprost BAK-preserved Ophthalmic Solutions on Human Conjunctival Epithelial Cells
Francoise Brignole-Baudouin et al.
CURRENT EYE RESEARCH (2011)
Ocular Surface Disease in Patients with Ocular Hypertension and Glaucoma
William C. Stewart et al.
CURRENT EYE RESEARCH (2011)
Ophthalmic preservatives: focus on polyquaternium-1
Maurizio Rolando et al.
EXPERT OPINION ON DRUG DELIVERY (2011)
A Correlation Between Latanoprost-induced Conjunctival Hyperemia and Intraocular Pressure-lowering Effect
Hiroshi Kobayashi et al.
JOURNAL OF GLAUCOMA (2011)
In Vitro Comparative Toxicology of Polyquad-Preserved and Benzalkonium Chloride-Preserved Travoprost/Timolol Fixed Combination and Latanoprost/Timolol Fixed Combination
Francoise Brignole-Baudouin et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2011)
Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication
Hannu Uusitalo et al.
ACTA OPHTHALMOLOGICA (2010)
Effects of Benzalkonium Chloride-Preserved, Polyquad-Preserved, and sofZia-Preserved Topical Glaucoma Medications on Human Ocular Epithelial Cells
David A. Ammar et al.
ADVANCES IN THERAPY (2010)
A Simplified Quantitative Method for Assessing Keratoconjunctivitis Sicca From the Sjogren's Syndrome International Registry
John P. Whitcher et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Prevalence of Ocular Surface Complaints in Patients With Glaucoma Using Topical Intraocular Pressure-Lowering Medications
Robert D. Fechtner et al.
CORNEA (2010)
Preservatives in eyedrops: The good, the bad and the ugly
Christophe Baudouin et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients
Michael J. Miyashiro et al.
CLINICAL OPHTHALMOLOGY (2010)
Preservatives in topical ophthalmic medications: historical and clinical perspectives
P. David Freeman et al.
EXPERT REVIEW OF OPHTHALMOLOGY (2009)
Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma
Christophe Baudouin
ACTA OPHTHALMOLOGICA (2008)
German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye
Carl Erb et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Prevalence of ocular surface disease in glaucoma patients
Eamon W. Leung et al.
JOURNAL OF GLAUCOMA (2008)
Ocular symptoms and signs with preserved and preservative-free glaucoma medications
N. Jaenen et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2007)
Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure
Carol B. Toris et al.
JOURNAL OF GLAUCOMA (2007)
The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review
Richard W. Yee
CURRENT OPINION IN OPHTHALMOLOGY (2007)
Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1:: An experimental study
Antoine Labbe et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2006)
Patient-reported behavior and problems in using glaucoma medications
B Sleath et al.
OPHTHALMOLOGY (2006)
Corneal and conjunctival changes caused by commonly used glaucoma medications
RJ Noecker et al.
CORNEA (2004)
Evaluation of the comfort of Alphagan (R) P compared with Alphagan (R) in irritated eyes
T Mundorf et al.
ADVANCES IN THERAPY (2003)
Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication
PJ Pisella et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Reliability and validity of the ocular surface disease index
RM Schiffman et al.
ARCHIVES OF OPHTHALMOLOGY (2000)
Share Paper
